Language selection

Search

Patent 3165081 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent Application: (11) CA 3165081
(54) English Title: EXTERNAL PREPARATION CONTAINING RAPAMYCIN
(54) French Title: PREPARATION EXTERNE CONTENANT DE LA RAPAMYCINE
Status: Compliant
Bibliographic Data
(51) International Patent Classification (IPC):
  • A61K 31/436 (2006.01)
  • A61P 37/06 (2006.01)
(72) Inventors :
  • YASUZAWA, TORU (Japan)
  • IGAKI, MATSUO (Japan)
  • MATSUMOTO, TAKUMA (Japan)
  • HIMI, SATOSHI (Japan)
(73) Owners :
  • NOBELPHARMA CO., LTD. (Japan)
(71) Applicants :
  • NOBELPHARMA CO., LTD. (Japan)
(74) Agent: BERESKIN & PARR LLP/S.E.N.C.R.L.,S.R.L.
(74) Associate agent:
(45) Issued:
(86) PCT Filing Date: 2021-01-23
(87) Open to Public Inspection: 2021-07-29
Availability of licence: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): Yes
(86) PCT Filing Number: PCT/JP2021/002352
(87) International Publication Number: WO2021/149827
(85) National Entry: 2022-07-15

(30) Application Priority Data:
Application No. Country/Territory Date
2020-009633 Japan 2020-01-24

Abstracts

English Abstract

[Problem] To provide an external preparation that contains rapamycin, has high stability and is efficacious in treating skin diseases. [Solution] An external preparation that contains (a) rapamycin, (b) at least one member selected from the group consisting of ethylene glycol salicylate, diethyl sebacate and triacetin, and (c) propylene glycol and/or polyethylene glycol, an external preparation that further contains an antioxidant, and an external preparation that further contains a solution of an antioxidant in a lipophilic solvent.


French Abstract

Le problème décrit par la présente invention est de fournir une préparation externe qui contient de la rapamycine, présente une stabilité élevée et est efficace dans le traitement des maladies cutanées. La solution selon l'invention porte sur une préparation externe qui contient (a) de la rapamycine, (b) au moins un élément sélectionné dans le groupe constitué du salicylate d'éthylène glycol, du sébaçate de diéthyle et de la triacétine, et (c) du propylène glycol et/ou du polyéthylène glycol, une préparation externe qui contient en outre un antioxydant, et une préparation externe qui contient en outre une solution d'un antioxydant dans un solvant lipophile.

Claims

Note: Claims are shown in the official language in which they were submitted.


WO 2021/149827 17
PCT/JP2021/002352
SI*0$1'2,1R1
[6115R1R1] (a) 5/7-1>9.
( b ) 1) )1.0k= L.> ¨)I.,
')
t 1
( c ) 7 M E ) ¨ )1,15z-rf /
= ¨ )1,
CE,X5R1R2] (a)
( b ) ') )1.nk= L. ')
h ')
7 7 -t ck ts ZgT75\ 63.atit ts < t 1 fa,
( c ) 71=I 1. ') ¨)1.Eztf/ =1,-
1,)
av,
(d) nt tiN =1-1,11A1.10
Hit *M3] (a) 7/74:>2J,
( b ) ') )
-ti-:>'./g3tf;=)1.)3W ')
7 -t ts g 75\ iint1R-,'S ts < t 1 Ms
( c ) 1=1 L :J ') ¨ / AI 1,) :J
¨ ) ,
RV,
( d 1 ) thIVEAIJOWEIEvItg't/V4A, 9.14101J.
[IERTR4] ( a ) ( c ) OMMEW, 1 : 2 0 1 : 7 c)
FA AIR 1
¨ 3 ok,\-r4-1,75\¨/Attgalca)M-JERAL
[iM5R1R5] ( b ) ( c ) OWAI.L75<, 2 : 1 2 : 6
5RIR 1 3
0)Oftt.75N¨MtLENC,O)M-M*1.10
[CRIA6] (a) (b)
(c) CDARthe, 1 : 20-80 : 20-70
got5RIA 1 ¨ 3 0)01'11,75\¨MtZ:38$540'HEHAU.
[gdt5RIA7] 4j-i1311LAIDY, Ei iirr> Liì (B H
T)
2 A--.(4. 3 CLE$,1C,OM-FRPic,
[II3RIA8] ( d 1 ) 0)titigtzeiLPJ0)*ZEITtglIC4Aes
6 H L Be5-7 0)
1 ia_Lo)V-A'ItIA-A-tiµ. 5RIR 3 t:Ei,k0M-1EMI.
CA 03165081 2022- 7- 15

WO 2021/149827 i8 PCT/JP2021/002352
[IA5R1R9] ( l ) ( d 1 ) th",k6M015Ehiltgtatz:_gg-4- z )5zz)
( i i ) ( i ) ttl-z_-_34A L.$),-F OD ( a ) ,
( b ) RV, ( c
) tii15RIA 3
tLEENC,01-JERAIJOt4a.
(a) 5/74:1
( b ) ') -t//:/K61=)liat)
1 II
(c ) ¨)1477.1f/ ttAt 1,1
[it**M1 0] T ( i ) tr:1-3k,\ -C,
6 H L B 7V 5 ¨ 7 0) 1 .PLoMM'ItAIJ
"1*m 9 lzp,2,$,li,a)M-1,101.Japt.,-.13.5.M,
[git*IR11] HLBe5 ¨ 7 OD 1 1.), 0E-Ailt01,1e, AI 1) 7J-
>-t
:=JOk -t Eaft
1 0 tLE,8a(DAJERPJOt43,SLA.
[g,m5R1Al2] ( ) ti-ACLAIJ -04' 6 tt. L,
( ) 1-:CFa) (a) , (b) R-Y (c)
-CM
(a) /'7-f
(b) 11/8k=1.%7')
l)77-t:,<t 9 ta:6U75\GIMR:s tt.6W=1:< Lt 1 fE
(c ) '1=1 ¨)1.13zzY/7-c.at I 1,:J'i)
[F,A3R1R13] ( ) 032 1-2rItt 7V, (z. HLBe5-701
'tjgd**TA 1 2 lzE,84C,OM-1ERAIL
CA 03165081 2022- 7- 15

Description

Note: Descriptions are shown in the official language in which they were submitted.


WO 2021/149827 1
PCT/JP2021/002352
te
: 7/7-1:/.'gq=HEHA-1.1
rkiird-31`f
[0001] 70AU, 7/74 <
7/74
k-Ziltt:{ 4143MV8Igt:15-tht.0=1-11]Alit:_111-0-Z.
14.*1-011i-
[0002] : Lx.)
Ke 5/7-r ,PAtiMIJI/F1,11-N -,:Lt\6,
(,:_fM/70,,tV84#7-LLC
c-c tc. Xs 1.) /slAw,njimj-0)
L --C JER tvc
3ff*--ettMVItRihgt:
1*-51SJSAgz_19),ILIVIIrVqL
[0003] /7-f Ute5 ¨3a1SaMOlgt/I(.7...
11;31-Z t op a), 2_1<tt12675LI-Z*;< VAU(z.ttULA,E'As!tIts.075\,
< Lo tc.iltRl,--C" o
[0004] 7/7-( '>:/M-JERPJL ---ClER tts '1411X --"S
VXM
t:-.3}ja 71Y105 1_, ct ta" s
f10)*' < 05741/A iztt
A, L7411 t\-5tt
7)1.
/tap, gt/X0DiaiRU,IAM
[0005] Nihr_ct
,fhAqd-R K. 75\--D, 7,1<04(,:_ct
31g-L's tt,g -to/tab, 7/
tatriih*A.gEli tc.MztalJel:A
tvrk,
5174:>-2(1)77)1.¨)1/4-gig-a
[0006]
¨ )1. -g--,ti=N )3MM801,00)*MC'ter4,-Ttt
5/7-f >JG)<t. -3 /".rin T 0 R KAM, I-AnkibliEztf122/141.1-gst,`,
A'r#:,.84#JERGAEREtz10.INCItterA7T7'_-t,-C-0 Z. 7 i=i
CA 03165081 2022- 7- 15

WO 2021/149827 2
PCT/JP2021/002352
¨)1/-75-74ta tt:t 0
A.1-14-A=liUM
*Ecth-R
[0007] 14t,cg1 : WO 2 0 1 8/0 3 1 7 8 9 1-1?L6
14,g11x.2 :WO 20 1 8/1 2 93 6 4
HA =N
_______________________________ effiM ct
[0008] *RHAtg:_LEVNtrligiw).--Cts.t(I-Litt oye9,
yj\.
-Ds gZujiltetEliXt Th-Leti* 5/'V-1 z =1-
1E101J
STEVRATZ 1st) C/D fR
[0009] ftlE111-g6tt, 77)1,¨), 75"-D,
so
IMICtsa V:rfrtig0C(7),t4)
ftfL
tti-ZV7-4t141,7)-,-,4D-ftz-L-__Lt:_cl: 9 irigiagnAWATZ
71Y --e zr:
[0010] ttsb-64\RHAtt,
(a) 5/7--(.:>1%,
( b) I) )1,Ott=1,
>ct 9 44:Zg75\6infR-4-1,Z,-_>44: t fis )3z-Y
( c ) 1=1 E' 1, ¨)145zzf/ tc. ¨
MdEHM--C.bZe
[0011]
(a) 7/7--f:>%,
(b)
)1,034t= led ¨)k -;:,:fft::;=)1,Ez-rf
9 tsZU75µ65RIR-41.Z,-/-s< Lt 1 Ms
(c) 7 D EA,
Rve
(d) ihitt4EAU, 91-1E101J-ez.
CA 03165081 2022- 7- 15

WO 2021/149827 3 PCT/JP2021/002352
[0012]
(a)
( b ) 1)-1) )1,gtt= ¨)k t.R.r.f
771t
t 1 fa,
(c) V'm L71,
¨)145zzf/i-LttAim)=1,:J'i) .. Ezzf
( d 1) ti-i,RMAIJogAtigrAgasUS 5O
[0013]
( ) ( d 1) t-
TAR4LAUMElitt-IgtEg4M-4-zTTI', Eztf
) ) 6 41. tz_-374 G) (a) , (b) , )37õ--(f
(c)
(a) 5/7-,
( b ) )1,)yw 1,
1) 7-t
9 43:Uli\63,EIR-L'_ttt.'-fa:< Lt
(c) 7 1=1E1, ¨)1/R-OVA-Lttt:1) = L.> "i)
[0014] *ftlElAtt,
( ) tak4 LAU *LEIEvIt',Fetlgr,=-V-M 4-1.Z3E-Itt L,
) 1-:CF0 (a) ( b ) Rlf ) -
cf4 6
UZM-JERAIJ-C.bZo
(a) 5/7-1.>
( b ) ,)
-t.,:,031.:;=)1.)3z:rf F. ')Y
:Jct 9 t-s6g75\ 41,6 ts < t 1g
(c) 7PQ E'1,:Js'i) ¨A/73W/
RBA DOJA
[0015] *HC: 9 5 7V-Talia)M*1-Z
4?1-Z t l'z'P_Iii=4:-T-30-Z3}/%30#1/$1J-tt.tz_-_-ZitarALNWAIJ, !t
(LM-1ERPJI'Z'14=kt J. LlYicftgLts.Z
ffi l'cgrigl]il
[0016] [M1A] 0= 5. ¨)1/7..Q4a, i)
B H TME-E.,qa
CA 03165081 2022- 7- 15

WO 2021/149827 4
PCT/JP2021/002352
04 0 tc:..80.Z : 1=1 (R4T)
[1511B]:im .A.GD=
1) /3, B H TAE-E;V-A
05 OtrFI') (MI+) -7iN-4--M-e.bzo
[12127a.g. %¨ o%0B
LtEckZ, 4 0 Ctzzl,t5 0
M4>Y4)
MEIJI tc-_621)0JFIR,
[0017] 5/IL
*13A0M4RAlitt,
(a) 5/7-1>%,
( b) o) -tii)1,)3z:y l i)
:Jct 9 td:ZU75\ 6int)R--= tt.Z < t 1 fE, EzZf
( c ) 1. ¨ 'UV ¨ )1,,
[0018] (a) 5/,:/t,
ViRopt
075q1JJEllJ5O*IEIAM,*(z.80-c
5il=1')1,..P1
6.14-L
[0019] G,z, 7/7-(:',./0DEA414sL
[0020]
NALI-*-i4¶:11- GT, 0. 0 5- 1 MR% TZ
t7TL,<(J-Ø 1-0. 8%, litLtzTl,<M-Ø 1 ¨O. 5
[0021] gta ( b) )1.gk
Ez-Y ')1t. MeiVil
[0022] (c) LCS
3ISIt 7VIVR 7 m EL,
00) 031'-altePT < ,
CA 03165081 2022- 7- 15

WO 2021/149827 5
PCT/JP2021/002352
th3 LT{ Lt Az
[0023] ( b ) L'4114 (c) aD3'.g Eh
4-Lts. o 75i', IN A_ a
, Affitb---es (b) : (c) =2: 1-2 : 6jtL
L< tt (
b) : (c) =2 :
[0024]
(a) 5/74>Lg4-ta (c) Lo3gt-LthLlf---ctt, 7/v-17
(b) L'74t1 (c) 03% iSatz:-MWT FR 9 izs-s kiN -c
41, ts
75<, INAJX, *a.b--c., (a) : (c) =1 : 2 0 1 : 7
< tt, (a) : (c) =1 : 6 o -e 9 , ',4174 ( b ) t=g/stpt..-=*.bb
(a) : (b) : (c) =1 : 20-80 : 20-70, Pfl_.><a (a
) : (b) : (0) =1 : 25 : 6 o 75T1J7T-,'s tt.z.
[0025] 4cRIE11109=1-1,101Jtt, thikihOIJ ( d )
M-
1,11McLiK,RMMA)in-4-z LcLct 9, /'v
,'R1411,R4
k-Zitfrgig-4-z eiThigLtszo A1*ntslyi,K6MAIJLLC
Ki=1-1-)1.= (BHT) ,
(B H T) 75qtm-s-,1,z
[0026] ii-ilk-fbM(DMEHLCtts -11PJ,f4ctz-JJ-L-c, 1-1 o mg%iyipj,-Ttt
< tt 1 5%.. L<1 ¨ 2 %eltrSt--,Ls=rt,z,
[0027] ihikihAUtt, litiga (a) , (b) ,(c)
eiThtg-e 65Sth",k6ThAi_1LEITIt-gat:igAq ( d 1)
,E (a) (b) Rzf (c)
[0028] -) tsVA,Itt/lAL 7 4 7 -f
t
>031211-tt (17211,'fb&'1bil<A) ff*t.f tIT < l,,A1J15 7
4 :J7V#IET--:_t 4-1,z 0
0029] tnitibPJ(z\-1-0-za-Aft-taoplJER2tt, ______________ 2kb T
: MAElistg-M
= : 1 o ¨ 3 : 1 o fati L<tz3 : 1 o
[00u] Ihit,fhMRATItgtat:374flq tc3458-z ( d 1) 6(z,
eiMICT.bZõL 5iiJ u--c tt, H L B IY 4 ^'
CA 03165081 2022- 7- 15

WO 2021/149827 6
PCT/JP2021/002352
7 0-59-AttAdeiN7T--..
tITL < (,J: 5 ¨ 6 0 1 ivs_Lo-9T-M,ItAiJ75TIJ7T
ttz o
[0031] -t tdz-57-11tAli Liz 9 ,
6 izgz-Z4b
zo
[0032] u-rtt, fIJAAX,
5- 7 I) 03÷" ') ') R-07J ') 7J- ib
14: z
63EtR--,'_ttLzWd:<Lt, 1 fi, PT'gl,<tt,-<Lt,24,0t,075,16tt,
Z.
[0033] Al*ntsV-M5t,ItAIJ01PJL L-C
¨ POE :
') = 1 :4 (ffi'Mth
)
¨
7 ') Ot0",)-ti) : P 0 ER,ILLEH= 4 : 1 (AtL)
tt. 0
[0034] *RHAODAJERAIRt, it=RIEI)10)03W4btita:00,1EITER4):FOILTZtc.
alp vc..AAJER
151i tS.
--c
)1.4LAIJ, YAMAIJ. P HIPMALIõVskAirnMJ-CM
JER 1,-CtP100
[0035] 172)1i1LMLL
1.J.tg:L Fil
.:>)(
Km**>7 DL J1,-
- )3z.'ff D>fD L')1.)4 j3)1,:./)<
11/L ¨A, )t 3)'¨A, t
PAPJ
451.1 tS, Ki=i-*=:i7P1=1E)1.--t)1/Q
¨ 11a tt.Z. p H L-C tt, 1PJ
airaR, wk. >R,
=:J0t6, s 11/0k,
if,)1,0t6G)AtiltAPpAIJ
77)14J 1) .1L-raõ 7 7 11, )3 I) tAIL-ra,tTJJ
lizo IEREWORL ttitibt
itcfbtI ') iL
[0036]
CA 03165081 2022- 7- 15

WO 2021/149827 7
PCT/JP2021/002352
rd:1-th0)Et
1J-75(,1µ tt.z o
[0037] M-JERAlioNiELM
it\RHA0M-MANJ--, 1-:CF0at: TWAT z e-e zo
[0038]
(a) 7/74:>:/,
( b ) #1) )1,031= L. '9 ')
9 tszgT75\65NIRT4-tz/.:vts< t 1 a,
)
z
[0039] tc..th",0#4LMJER Ztai
( d 1) WEIEItigtat,7-74g3-4- RV'
( ) g J10) (a) , (b) , Ez-ef (c)
(a) 5/74,
( b ) -I)-') ,Ez-y
9 ta:ZET75` t 1 fis
(c) 7 1=1 ') ¨)1,/kt/V tc. tt I) = V' 1)
¨)1.,
tµga o
[0040] UT, ct V-/-1t0)-64091-1,101JV4z1-c_apt:_,
( ( d 2) t-tk6MALICdEpt-g-t74t,=-'411q G-c3MH-A11704
HLBe5-7 0) 1 iv,_L0)-57-M5tiltAi] A_ Ez
TY
( ) ( --(14 tt. tc374 -F
(a) 5/74:>%,
( b ) JI/nt.=
1) -t
9 tszET75\61afRsti.z/-/-s< t 1 fM,
(c) 1=1 ') ¨)I.Ezt/V ttt I) I)
vg.A 1-5/7-f -:-,o)V7.1<tt5t/E74-A] Lf15-4-ztaat,z)
9_wat,--ct,tk,\0
CA 03165081 2022- 7- 15

WO 2021/149827 8
PCT/JP2021/002352
[0041] _LE
0`)'1 ( d 2) tz=s-30---c, tj-i-,k6mOdRATItgtatz..-.MT
_L
E8 (i i)
,7'-1'>
007_1<ti-V-t/Z-74-A oDtVgit -1,46z
[0042] *RIEIA0M-JERlitt, *31_Ats#R4):F,S, ¨ AU, ¨
') )0X, WIX7J-0) 01, =
01-thORATlIgi-c.tthlIP_Itz..hr
, 7
F.5 flJ I TL.
t/l/Alk-f/)4/11.0¨,
5=s* '.)%,
E=J1/7
A1) 7 ')/1/b.t h ') As )4 h*:-/=1,>¨,<71,-r :Jot
') ') 1:1 fa: 0)
¨ ;
1=0, 7J-I)¨A, tt7J-A,
,)
,r7-t >ts eo -t =4A
; 4 ANJI 74
(//)14tA4L7KA)
; 7 1) ; ') 11,8k=T-11/, ') :/831= -
7J-:i5k
7 ;i)JLiJf
¨)Ii; K5'://1. L71=1 I) FJ ; FKX, ;
%.PJ ; ')
; 7J- I)
6k4L.1-tas 75,6iNattz
1 J-,k_L .3V-AWI-J-4- (71 õ
[0043] 91-111AdiDitfl
*R13/10)5/7-1':>%-git'idEllPitts ,ff-A'fAl$1.11/FlERA

IP] A_ tS1Z,SA10,058.0t:-JER0 zr: LIYUifC--e Z.
[0044] 1441WSEM4-0,0)1Pi
k L. ¨
Am=maµg, InTA, ;ns, '7- 1=1 K. il'AR,FaLiVrtt
iJNA, -3 --MiltiZM'As
mottRibaozaarc 1]8N
ffi,9))31,411EfA4751 tl.Z.
[0045] *RHAOM-l'HAliC'HOtc-MenOIR4Iffitt, _________________________ *tK,
CA 03165081 2022- 7- 15

WO 2021/149827 9
PCT/JP2021/002352
rA,h1-1::-,t 9 tt. es INA_ tX`I-JER JER ti
1-`1 tt,
717-f 01-1 00mg/m2
____________
A) _________________________ 9 IR4-1-Z e
[0046] 1-:CFV:-Ai*ntcr*-11) ,e.*ti-C*RHA 'TARA e,
t OD-C; < Z017 tcl-
7_RM)3z2)7..'77YR
'N-014,Wilil5ROMIRIt:jR,t-,'S tt.,4K1t1=910CIRItc.ttg_Rgii,
4-04 75qtflg tLZ.
[0047] ,.*=01_1 1
1 rj---71-*11-11,7_,
: g-we : 5 0 (mg
t) Ls V95 0t0)71<41=1=r-ChUND'.1_,--
CkEA5N9g41-
TrL'H4EtEML-C-7411q'ItfiggE OMM, ____ 1 LJZk
(PE )
-j) 2, TA 6,.)4,Apit
017-011
1JJi
I- .9 Y 9 -t 9 r 2FiV, (*-
9 :-T-",r67: CO.
12-f v)
(* V.)
.2. 'Tz
7 T:1 V ) "FM- (t-z- R)
:_1-1 e)
4 0 0)
1, 3 77 (:*
[0048] 1=1 I)
H P CgiUR"ffo, MOttNITITIOD:>Q1)14E'-
CA 03165081 2022- 7- 15

WO 2021/149827 10
PCT/JP2021/002352
[0049] WiTA-1 = _____________________________ 9i- PR Y6 .A Pit
(Ad Z.5)SM< . 2 7 8 n
t5b. : 6 mm,
25Omm izF15
t7L.2.1.:40tN3E.0¨ZE.I.
4th$F1 : 7 ')/1./0. 0 2 m o I /Lfilfgi'77":)=.z.,a-gi-
34I(p
H6. 0) = 1 3/7
= : O. 8 m L/3}
[0050] *-1-thiN 1 , .FL$3`tiN 1
1 tEgaef,a)-gtIL Ei Lc: ¨ )1, 1, 1:73.1'
= ') : : ¨.)1.7V 1 : 5 0 : 2 5
(ffiffi_bL) L td:
51.gir , *j5 0 t (07.1< 1=0 -Ch1:131% -rei-a3glEr,,4A4
Asg$4
tco tt.tc.I4M Ifl *NV LLOZ9 ER.
[0051] glqiltOMW 2 t,=,-T-4-e ')
Ez-Y, 77-t-vL Fi ¨ L 03'1' ACEH
= 9 , i=i ') Ogg efFNE:S
[.s2]
(A. 2)
ra" Ly=' __ ,Y ( P G) 60 13.A !) .1,
.7. Q.,)..j1104_-,
raA-
ffiTit
i I tk 1- 9 ( a4tf1411)
P G
YEIN I----I 9 9
PGiVf
2 -1-z 7E- PG
it KM I ---- 2 t:: (*.40)
PG
3 1)7vPG
t;ii------- 3 :4 P G T:if(7 ( 2 V: ;MO
Lf1I------- 4 !) (--'=7 '11,7 47' -1V)
:1-- it,' 4 0 0 ) PG
,ttiKtl --5 1, 3 !.;
[0052] A, 7' 1=1 E' 1, 0)N4-) Ai' 1) L.
¨A/CI]
CA 03165081 2022- 7- 15

WO 2021/149827 11
PCT/JP2021/002352
JER 4/MI -C t Ra05-75q41 tt.Z.
[0053] tfP.1 2 ---- 3 (ti-tAt4L1.10)Re.10)**g1")
2 % gl_hti -Cg1F4
tc3-1-2,5A(iCF % 1=1 ') ¨)1/AQ7-451I LT-15t) , a-Cf:>
¨ 11.7_1<g-541(Z, B H T 1 %LtSZck--)rj-EEIS',#tz_:34I
= ') B H T 8E -117-14a f-15
FAN L Fl B H T
fia EDTAJ-1.1) 71tztt M
)1411FR t r,
)in L tc37434111713,11 1) ¨
DI) /3.,B
H T ne,a7-4a0)-41.T.'41.1E-D 0-C, 4 0 C)37.7f 5 0 t --efX4 Lis 7 El4rETIAR
tf 3 0 11411,1"*ODMWE Z, _LE PittIC
i1=1 _L-xig)n#4< ,
[0054] Eztflai 1 A, BL7T-4-
0
:>I=1 ') tt,
= Lt ee-F Z Otc.,(,fli 2 )
1=1 ') B H gE g-Atz.= (t,
(;:.3vtt,
CAVE eigiA A. 6 tt:r it (4.%-fli 3 )
[0055] [3]
(õP 3 )
lAtitiLM 1CitstWiri
(A) ( A)-.-EHT *EDT A (A-BHT
A ,-BHT
;INo.6-2) (N0.3-
4-2)
0.2 g 020 g 0.20 g
0.20 A
õ 49.42 g 49.42 g 49.42
g 49.90 g_
BHT
0.10 g 0.10 g 0.10 g_
EDT A-Na g
=;_-L Ert ktma 0.10 g
g
50.38 g 50..26 g 50.18
g 50.00 g
100.0 g 100.0 g 100.0 g 100.2 g
CA 03165081 2022- 7- 15

WO 2021/149827 12
PCT/JP2021/002352
[-t4]
(P. 4)
B H T
40'C $fyr.
S7.3 38,4 80,6
2,7
=ZHI" 954 S74 89
7 13.0
.1A)
(A) +BliT o83-1 ECM
[0056] ____________ 4 ( B H T ogalsigow,q)
1).A.0)=37 J ¨ Ji474341t,¨_. fV7o3M,M.0) B H T
, 4 0 C Eztf 5 0 C 2 EirmR4 ito
_.=01J 2
g 00 ='ff o
5
efiegE-.'S
[0057] [5]
(V. 5
BHT t2 te
11111111111111111111E3111111311111012111
96,73 90 357 9' 0,41
, =
9E Sk3,. 96,8 SE 42 90,1":
95-65 k-25
[0058] -A%41J 2 (filelti BHT on-E;)
1. 6%LtSZ,t tz_z4A,1171N 1,
7 D E ))i,D 1 . 6'Yo :Lz i tc.
ZEIM 1=1 I)
1.1 (Zs BHT .5' fyq
L54A (
CA 03165081 2022- 7- 15

WO 2021/149827 13
PCT/JP2021/002352
JF B H 5'4A Lf15-4- ) 014
[0059] Ei I) .L.'74ALBHT 7
: 3OU5L 1 10
00m i n-1 (DA-4-e-A311114*-'ff tco
ti.tc.A 3 134172IME
(----tZtE=/ff-Dko
TC*1-4-/*(,R,t=O- ti-iRtL321-4-1.-Cotc_
34-0Y, 2 $n Lk
[0060] -4r0IJ 3 JFI .6.74'ffIL B H /17-Siti.B5a7A
C tvr kiN a 17 6 t,7_771-11J-
,S-e3MISL,
/7 (1) H
B H tz_-_ 1 3 %L
riVEFF ( 5
0-6 0 C) --e,t)inL1
,113'ip ') .L).543,TY.L 6 2 : 3 8O) --e
L.. 11000mi n-1 ODA1t-e-AitAti-*-170, -%00-t4JO co
.14 ttitt4M 2 2 FlepliaN Ls Ifl*ta-CAGAX,%tõPV tco
[0061] IfIV,M,00eW, ..59-;'tiltAij a Ez.-Y b JER tc_t4*XC3AtE
fa: < , 1E1 t, 3'1' =IX eV-Zt P.: WC tc o H L
B
7. 2 5 1LO).51-tiltAIJCER tz_-_:&Ali (,*H3AfE -C"
Jh C3AfEti11$1J1- tcobt:..tt, H B IFA 5
¨ 7 0.n
CERoZz: e LjUtLtc0
[0062] [.y..6]
(W 6 )
03+N 0 /AEI
L B ftito
a b
P 0 E ( 1 0 . 0.2 0.5 0.8
5)
).1 -L-* 9 ..>"' 0.8 0.8
ft 5 0.2
(4. 0)
P E ( 1 4 . 0) 0.2
F. 6 0 (i 4 . )
1.0
ii.A.V15: H. B 5.8 6.0 7.25 9.2
14.9
[0063] --rn*Wli 4 Ez-ritLCHN 2
CA 03165081 2022- 7- 15

WO 2021/149827 14
PCT/JP2021/002352
-FliaotA--ettix-OliNt4 Lis 50 t-e1S4 t_,-c 2 3FgrEMRZ4 MITEMZ=S-3
1) Litt
[0064] (- -rtim 4 )
if)1,4LP-14LzKAt:jcl 1_õ .391,0Alit.j.3"4 Z 0 .
2%J
¨11,31.11a 7-t 'vs 7 F1 ¨)tiEz
¨)I, iTilliS`--e3g tc.341)
iW
, B H vAtii 7 4
B H T 75%141-MtEZ-1 -C 1 . 5 % tSZ
(Zs WM5titPi(E12T- 1) >gg",.) )
.=R
E. >51:11 O)31 H B = Vg 6 44: r:31.1)
3L1t_-_
)72)t,,tg,t7.1KA0D-A-AVYAll-MoAig 7 5 %Lts.Z,t r_171U LtcL
)1/1to)VOM ts tc.õ
[0065] (tht'dm 2)
if)1,4b)74LzKZ(.,=-1_õ ,i'74:39/41Alitr.3"41_,-C O. 2%Lta:Z,t
)31:1 tc. lill/iLAMZKAID-gE75%VAIJO)Pg 8 0% ta:
(Z..,171V
Utz= , )1,1A0V7* 'D It 0
[0066] 7 0-Y..`. B H T
ots0VM (th$3ZIN
2) tt1*4141JrimoDuArlq-D
Or)R4'&755k(Zia-F1,OD
tL BHT 1-`1 tc_OM (llOg 4 ) T
1) L. R4141(De-F
7Ytfpfri.. 641., UT 7Y1)75` 60
[0067] [-s,7]
7)
r? 9
141411ff '.=;) 2 i9 ("7/c, 4
iffirtM
/fJ2 1 00 5 5 . 1 9. 2
.=-j¨:-Aifi1 1 4 1. 0 0 9 7 . 3 9 7 . 4
[0068] -*'rtb,111 5
WX*050AMTA.
CA 03165081 2022- 7- 15

WO 2021/149827 15
PCT/JP2021/002352
VRIMML -*'%01.1 tz-_ -UMW L, :> 1=1 JER
52)1.
LLZMetTec Co rpo rat iont.40)EFT-400-vi,
MOT, V-1.10/Z52/1/".05.1.3AriAM-'ff
EFT-4007V -t igt-the3}
4-1,tc. 6 r, =)I.7 ¨ ts7:13M52)1.
--C;ZASEJ84L, 0..0kilileA.Kri (3 7 C, 5 %CO 2, Nzgkit-F)
-m.fk ( 1 6 ¨ 1 8134174) 4 I*/ k- 3- ¨FL/
[0069] MMR*19 5 0 m 9
ZNigANIEJ8017171*531,:*
irktnkiltlaR.2,; (3 7 C.. 5%002, t-F)
2
4 H4 rA k- F- A:. 4 k- ¨ 413_ T =1C MCA-
6-ff-i-z_-_JIMMo-caup_EaD4RIMN 3 El tit
=1.0)7..1<
3.KLtc0,A)M
Ft Us gti.1-ZLtO
[0070] tlitZ tc.A 1 m Z(LLkO
3,V,\3}-,ttE ( 2 0 4 0 0 X g , 5 3}111, 4 C) L, _LAff3w4AL
4R1-tt L ap Wfir
-alit& tz_-3-g-A
Vs5:17 I- I) 1¨)16-
7g43"x
2 0 n /m .,7,17tT Us 153471-V'fr-ttW-74-AL Utz
[0071] ,104;WAYJJ7ZI- ')771 igtz-ASTRIC
O2 0 ,u, L
P P ¨It:JUR utco =-= to,: -fr
') )1/2 0 L itr,13*,7õm54
2 0 . L, }¨)L'5 0 L
3HL.. -FEODitiOLC/MS
/M S vc_IR -3c/. 1=1 A 564
L, Ito 14 Utz= 1=1
) AM1.0)111 L MA-',74AFFAt4tLJER tc.A&M, oN L 1)\
t:if4"ff
tc.% 1=1 I) -A oNSI Ni+, Lk. A)ZEt:_f4"ff 1, :> 1=1 i) iNoDNAL*
4-0-cM-MN 1=0
1=1 i) iNaDNAL 75\ 6, *'co* of__AFrAl
Atz31-1-z%) .*e5/3tzr..
:>1=1 iNa),A)ZE-NofVff*tt, 1
. 4 0 2 (A)VERAtLt,11-Z%)
3}1ZEM.55MiteigittL-COZ
L
[0072] (L C#)
CA 03165081 2022- 7- 15

WO 2021/149827 16
PCT/JP2021/002352
t -A
Omrn, att 5 Omm0)5-":-./1.,M1, 1=17F¨Ys77
¨JER )1,4L.:',
tAaft:50tflo)--k-Mft
6mL/3-}
45)A : 5mmo /1-1#77%=.L.1, (AA) ¨)1,
(BA)
[8]
(.8)
N +A-
T 1 rn e I B (%)
n )
n i 1: i a 1 2 0 0 8 0 .
0
O 80 20. 0
80. 0
= 8 1 1 0 0
9 0 . 0
1 . 1 0 .1. 0 . 0 9 0 0
1. 11 20.0 80.0
4 0 2 0 0 8 0 . 0
(MS/MSW
= ,J- : ES I
:Positive
..*-A-7.:..--(7 :MRM(multiple reaction moni
toring)
(m/z, Q1>03) (931>864)
(809>756)
&_LogDf1JJEH rTagft
[0on] *R8At:ct(J,574:'../V74Mitt:%4-1,1tVZ-eABM,o4ff
-140M-JEMIX141-
=-__LIPThIgLtszo -01-cest), 4REI)ItL,t9, 7/7
Z: gLtd:
CA 03165081 2022- 7- 15

Representative Drawing

Sorry, the representative drawing for patent document number 3165081 was not found.

Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date Unavailable
(86) PCT Filing Date 2021-01-23
(87) PCT Publication Date 2021-07-29
(85) National Entry 2022-07-15

Abandonment History

There is no abandonment history.

Maintenance Fee

Last Payment of $100.00 was received on 2023-12-27


 Upcoming maintenance fee amounts

Description Date Amount
Next Payment if small entity fee 2025-01-23 $50.00
Next Payment if standard fee 2025-01-23 $125.00

Note : If the full payment has not been received on or before the date indicated, a further fee may be required which may be one of the following

  • the reinstatement fee;
  • the late payment fee; or
  • additional fee to reverse deemed expiry.

Patent fees are adjusted on the 1st of January every year. The amounts above are the current amounts if received by December 31 of the current year.
Please refer to the CIPO Patent Fees web page to see all current fee amounts.

Payment History

Fee Type Anniversary Year Due Date Amount Paid Paid Date
Application Fee $407.18 2022-07-15
Maintenance Fee - Application - New Act 2 2023-01-23 $100.00 2022-07-15
Maintenance Fee - Application - New Act 3 2024-01-23 $100.00 2023-12-27
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
NOBELPHARMA CO., LTD.
Past Owners on Record
None
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Declaration of Entitlement 2022-07-15 1 24
Description 2022-07-15 29 688
Claims 2022-07-15 4 65
Drawings 2022-07-15 2 20
Patent Cooperation Treaty (PCT) 2022-07-15 1 66
Description 2022-07-15 16 588
Claims 2022-07-15 2 57
Drawings 2022-07-15 2 85
Priority Request - PCT 2022-07-15 21 909
International Search Report 2022-07-15 3 113
Patent Cooperation Treaty (PCT) 2022-07-15 1 55
Correspondence 2022-07-15 2 48
National Entry Request 2022-07-15 9 256
Abstract 2022-07-15 1 13
Cover Page 2022-10-06 1 32
Abstract 2022-10-06 1 13
Claims 2022-10-06 2 57
Drawings 2022-10-06 2 85
Description 2022-10-06 16 588